Cargando…
Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus
Lipid-lowering therapy is used very commonly nowadays not only for the optimization of the lipid profile but also to reduce cardiovascular risk. However, some studies have linked the use of certain lipid-lowering agents with an increased risk for impaired glycemic control and new-onset diabetes mell...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioExcel Publishing Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267678/ https://www.ncbi.nlm.nih.gov/pubmed/30515229 http://dx.doi.org/10.7573/dic.212562 |